Skip to main content
. 2025 Oct 12;17(10):1323. doi: 10.3390/pharmaceutics17101323
BCa breast cancer
BMs bone metastases
CT computed tomography
GRPR gastrin-releasing peptide receptor
GS Gleason score
IHC immunohistochemistry
LNM lymph node metastases
MRI magnetic resonance imaging
PCa prostate cancer
PET positron emission tomography
PSA prostate-specific antigen
PSMA prostate-specific membrane antigen
SPECT single-photon emission computed tomography
SUV standardized uptake value